10 Likes Seeing hidradenitis suppurativa differently: what 2026 has taught me Posted by Viktoriya Moroney, HS Marketing 20-Nov-2026 Working in hidradenitis suppurativa (HS), I’m constantly reminded that there is more to this disease than we can see.That has felt especially true in 2026. Through the research, conversations and people I’ve encountered, I’ve found myself looking differently at how HS progresses, who may be living with the disease and what we still need to learn.As we reflect on the final major HS congress of the year, the Symposium on Hidradenitis Suppurativa Advances (SHSA), one thought keeps coming back to me: the more closely we look, the more there is to learn.Looking beneath the surfaceOne area I’ve been thinking about a lot this year is inhibition of progression.HS can look very different from one person to another, and it can also change over time. That leaves us with an important question: How can we help people living with HS today, while also helping to reduce the risk of their disease progressing further?In part, this means looking beyond what we can see on the surface. HS may be diagnosed through symptoms such as abscesses on the skin, but we know the disease can change over time, with significant structural changes also taking place. Tunnels can develop beneath the skin and are associated with inflammation, pain, quality-of-life burden and irreversible structural damage. These changes can begin before tunnels are clinically detectable, and ultrasound can help reveal what clinical examination alone may not.For me, that raises an important question: how can we understand not only how someone’s HS is affecting them today, but where their disease may be heading tomorrow?I’m particularly excited by our biomarker research with Stanford University, which is exploring structural and biomolecular differences between people whose HS progresses at different rates. The hope is that, over time, this could help us better understand who may be at greater risk of progression.We’re not there yet. But I believe that the more we understand about progression, the more opportunity we have to think differently about the future of HS care.Looking again at who we might be missingSeeing HS differently has also made me question some of what we think we know about who lives with the disease.HS has long been understood to be more commonly diagnosed in women. Yet new UCB-supported research involving 2.4 million people found that HS-related symptoms among people without a formal diagnosis were similarly prevalent in men and women. Men living with HS may also experience a longer journey to diagnosis.It made me wonder: could more men be living with HS than we previously thought?For me, it’s a reminder to keep challenging assumptions. Understanding HS isn’t only about what’s happening beneath the skin. It’s also about seeing who we may be missing and understanding the person living with the disease.Listening is part of learningSome of what has stayed with me most this year hasn’t come from research.At UCB's 2026 HS Patient Partnership Summit, 20 HS advocates representing 17 advocacy groups across 14 countries came together to connect, exchange knowledge and co-create around the unmet needs of the HS community.Listening to those voices reminds me why all of this matters. Science can help us see HS differently, but listening to people living with the disease helps us understand where change is still needed.So, what has 2026 taught me?Look deeper. Question what we think we know. And keep listening.I’m encouraged by how much our understanding of HS continues to evolve, but I’m even more motivated by how much there is still to learn.As I look to 2027, I want us to keep pushing the science, challenging assumptions and, above all, keeping people living with HS at the heart of what comes next.Because the more we see, the more we can understand. And every step forward brings us closer to the future we want to see: an HS-free world.Read more about our progress towards an HS-free world in the UCB HS Vision Report 2026. Leave a Comment You must have JavaScript enabled to use this form. Please enter your name Please enter your email address By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here. CAPTCHA Get new captcha! What code is in the image? Enter the characters shown in the image. Leave this field blank